These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29084686)

  • 1. Effects of telmisartan on paroxysmal atrial fibrillation in hypertensive patients.
    Li J; Chen H; Zhou Q; Hu L; Ma L; Han H; Li W; Du R; Tian L
    Pak J Pharm Sci; 2017 Sep; 30(5):1651-1655. PubMed ID: 29084686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation.
    Zhao Z; Niu X; Dong Z; Qi W; Liu E; Liu T; Li L; Liang Y; Li G
    Cardiovasc Ther; 2018 Dec; 36(6):e12478. PubMed ID: 30390409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
    Du H; Fan J; Ling Z; Woo K; Su L; Chen S; Liu Z; Lan X; Zhou B; Xu Y; Chen W; Xiao P; Yin Y
    Hypertension; 2013 Apr; 61(4):786-92. PubMed ID: 23438932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
    Fogari R; Zoppi A; Maffioli P; Mugellini A; Preti P; Perrone T; Derosa G
    Clin Cardiol; 2012 Jun; 35(6):359-64. PubMed ID: 22522403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.
    Fogari R; Mugellini A; Zoppi A; Preti P; Destro M; Lazzari P; Derosa G
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):34-43. PubMed ID: 21335482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoring sinus rhythm results in blood pressure reduction in patients with persistent atrial fibrillation and a history of hypertension.
    Sanders NA; Bertolone C; Jetter TL; Wasmund SL; Croci F; Solano A; Brignole M; Hamdan MH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):722-6. PubMed ID: 22494504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.
    Qi WW; Liu T; Xu G; Li LF; Liang YZ; Ye L; Li GP
    Trials; 2015 Aug; 16():336. PubMed ID: 26248619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.
    Pan G; Zhou X; Zhao J
    Cardiovasc Ther; 2014 Aug; 32(4):184-8. PubMed ID: 24645740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.
    Galzerano D; Di Michele S; Paolisso G; Tuccillo B; Lama D; Carbotta S; Cittadini A; Tedesco MA; Gaudio C
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):496-503. PubMed ID: 22546623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):217-22. PubMed ID: 18356684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients.
    Guthrie RM; Dahlöf B; Jamerson KA; Olvera R; Seeber M; Schumacher H; Oigman W
    Curr Med Res Opin; 2011 Oct; 27(10):1995-2008. PubMed ID: 21905967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
    Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Atorvastatin on Serum High-Sensitive C-Reactive Protein and Total Cholesterol Levels in Asian Patients With Atrial Fibrillation.
    Wang J; Wang AR; Zhang MJ; Li Y
    Am J Ther; 2017; 24(1):e20-e29. PubMed ID: 26566148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
    Okin PM; Hille DA; Larstorp AC; Wachtell K; Kjeldsen SE; Dahlöf B; Devereux RB
    Hypertension; 2015 Aug; 66(2):368-73. PubMed ID: 26056336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Mourtzinis G; Schiöler L; Kahan T; Bengtsson Boström K; Hjerpe P; Hasselström J; Manhem K
    Eur J Prev Cardiol; 2017 Jul; 24(11):1206-1211. PubMed ID: 28470087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment-Results from the Randomized TEAMSTA Protect I Trial.
    Jagodzinski A; Neumann JT; Ojeda F; Sörensen NA; Wild P; Münzel T; Zeller T; Westermann D; Blankenberg S
    Clin Chem; 2017 Dec; 63(12):1877-1885. PubMed ID: 28904053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.